Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "strategy"

1055 News Found

Omega Healthcare to expand operations in India
Healthcare | May 10, 2022

Omega Healthcare to expand operations in India

Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions


Bora Pharmaceuticals acquires Eden Biologics CDMO assets
Biotech | May 10, 2022

Bora Pharmaceuticals acquires Eden Biologics CDMO assets

Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market


CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine
Biotech | May 10, 2022

CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine

CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium


InxMed raises US $ 15 million in Series B+ financing
Startup | May 09, 2022

InxMed raises US $ 15 million in Series B+ financing

The plan is to advance innovative therapies to drug-resistant cancers


Challenges of Thalassemia management in India bring like-minded stakeholders together
Public Health | May 08, 2022

Challenges of Thalassemia management in India bring like-minded stakeholders together

Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India


Gut microbiome as a tool in regenerative medicine
Biotech | May 07, 2022

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses


Procter & Gamble Health posts 14 per cent growth in net profit in Q3
Biotech | May 06, 2022

Procter & Gamble Health posts 14 per cent growth in net profit in Q3

The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year


Merck invests $110 million to expand production site in China
News | May 05, 2022

Merck invests $110 million to expand production site in China

Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities


Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


StanPlus appoints Gurjit Singh as COO and Founding Member
People | May 02, 2022

StanPlus appoints Gurjit Singh as COO and Founding Member

He will be leading the business, operations, P&L, and growth strategy for StanPlus